Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.
2.

Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.

Pantano F, Brauneis S, Forneris A, Pacifici R, Marinelli E, Kyriakou C, Pichini S, Busardò FP.

Clin Chem Lab Med. 2017 Aug 28;55(9):1324-1331. doi: 10.1515/cclm-2016-0990.

PMID:
28080998
3.

Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.

Neuvonen M, Neuvonen PJ.

Ther Drug Monit. 2008 Jun;30(3):333-40. doi: 10.1097/FTD.0b013e31816e2d4b.

PMID:
18520605
4.
5.
6.

Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.

Gaudette F, Sirhan-Daneau A, St-Onge M, Turgeon J, Michaud V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:174-180. doi: 10.1016/j.jchromb.2015.11.035. Epub 2015 Nov 23.

PMID:
26655109
7.
8.

Observations of urinary oxycodone and metabolite distributions in pain patients.

Elder NM, Atayee RS, Best BM, Ma JD.

J Anal Toxicol. 2014 Apr;38(3):129-34. doi: 10.1093/jat/bku007. Epub 2014 Feb 11.

PMID:
24523296
9.

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.

Lalovic B, Phillips B, Risler LL, Howald W, Shen DD.

Drug Metab Dispos. 2004 Apr;32(4):447-54.

10.

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

Stamer UM, Zhang L, Book M, Lehmann LE, Stuber F, Musshoff F.

PLoS One. 2013;8(3):e60239. doi: 10.1371/journal.pone.0060239. Epub 2013 Mar 28.

11.

In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.

Moody DE, Liu F, Fang WB.

J Anal Toxicol. 2013 Oct;37(8):476-85. doi: 10.1093/jat/bkt060. Epub 2013 Jul 14.

PMID:
23857299
13.

Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.

Naito T, Tashiro M, Ishida T, Ohnishi K, Kawakami J.

J Clin Pharmacol. 2013 Aug;53(8):812-8. doi: 10.1002/jcph.112. Epub 2013 Jun 3.

PMID:
23733622
14.
15.

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.

Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, Rossier MF, Hochstrasser D, Dayer P, Desmeules JA.

Br J Pharmacol. 2010 Jun;160(4):907-18. doi: 10.1111/j.1476-5381.2010.00673.x.

16.

Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.

Chan S, Edwards SR, Wyse BD, Smith MT.

Clin Exp Pharmacol Physiol. 2008 Mar;35(3):295-302. Epub 2007 Oct 31.

PMID:
17973932
17.

CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone.

Naito T, Takashina Y, Yamamoto K, Tashiro M, Ohnishi K, Kagawa Y, Kawakami J.

J Clin Pharmacol. 2011 Nov;51(11):1529-38. doi: 10.1177/0091270010388033. Epub 2011 Jan 5.

PMID:
21209234
18.

Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.

Cone EJ, Zichterman A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH.

Forensic Sci Int. 2010 May 20;198(1-3):58-61. doi: 10.1016/j.forsciint.2009.12.005. Epub 2009 Dec 29.

PMID:
20036472
19.

Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.

Cone EJ, Heltsley R, Black DL, Mitchell JM, Lodico CP, Flegel RR.

J Anal Toxicol. 2013 Jun;37(5):255-64. doi: 10.1093/jat/bkt031. Epub 2013 Apr 21.

PMID:
23609023
20.

Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.

Cheremina O, Bachmakov I, Neubert A, Brune K, Fromm MF, Hinz B.

Biomed Chromatogr. 2005 Dec;19(10):777-82.

PMID:
15920700

Supplemental Content

Support Center